Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BetterLungs Mullein + Chlorophyll
- Development stage
- Preclinical
- Lead developer
- Betterbrand
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral, Sublingual
01
Overview
BetterLungs Mullein + Chlorophyll is a commercially available dietary supplement developed by Betterbrand, a PharmD-founded lung health supplement company. Formulated as a liquid drop tincture, the product combines mullein leaf extract, a traditional botanical herb used to aid mucus clearance and soothe the respiratory system, with chlorophyll, which is recognized for its anti-inflammatory and antioxidant properties. The supplement is designed to support respiratory wellness, clear airways, ease coughing, and reduce fatigue. A 60-day randomized, triple-blind, placebo-controlled clinical trial conducted by Citruslabs demonstrated statistically significant improvements in breathing comfort, mucus clearance, and energy levels in adults. The product is third-party tested by Eurofins Scientific and is sold at major retailers including CVS, Walgreens, GNC, Amazon, and Walmart.
- Brand names
- BetterLungs Mullein + ChlorophyllBetterLungs Mullein + Chlorophyll DropsBetterLungs Mullein + Chlorophyll Tincture
- Other names
- mullein + chlorophyllmullein and chlorophyll
Beyond the preview
Go deeper on BetterLungs Mullein + Chlorophyll.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BetterLungs Mullein + Chlorophyll.